729 related articles for article (PubMed ID: 25842390)
21. Dietary Lycopene Supplementation Improves Cognitive Performances in Tau Transgenic Mice Expressing P301L Mutation via Inhibiting Oxidative Stress and Tau Hyperphosphorylation.
Yu L; Wang W; Pang W; Xiao Z; Jiang Y; Hong Y
J Alzheimers Dis; 2017; 57(2):475-482. PubMed ID: 28269786
[TBL] [Abstract][Full Text] [Related]
22. Selective suppression of the α isoform of p38 MAPK rescues late-stage tau pathology.
Maphis N; Jiang S; Xu G; Kokiko-Cochran ON; Roy SM; Van Eldik LJ; Watterson DM; Lamb BT; Bhaskar K
Alzheimers Res Ther; 2016 Dec; 8(1):54. PubMed ID: 27974048
[TBL] [Abstract][Full Text] [Related]
23. The GLP-1 receptor agonist liraglutide reduces pathology-specific tau phosphorylation and improves motor function in a transgenic hTauP301L mouse model of tauopathy.
Hansen HH; Barkholt P; Fabricius K; Jelsing J; Terwel D; Pyke C; Knudsen LB; Vrang N
Brain Res; 2016 Mar; 1634():158-170. PubMed ID: 26746341
[TBL] [Abstract][Full Text] [Related]
24. Increased O-GlcNAcylation reduces pathological tau without affecting its normal phosphorylation in a mouse model of tauopathy.
Graham DL; Gray AJ; Joyce JA; Yu D; O'Moore J; Carlson GA; Shearman MS; Dellovade TL; Hering H
Neuropharmacology; 2014 Apr; 79():307-13. PubMed ID: 24326295
[TBL] [Abstract][Full Text] [Related]
25. Neuropathogenic role of adenylate kinase-1 in Aβ-mediated tau phosphorylation via AMPK and GSK3β.
Park H; Kam TI; Kim Y; Choi H; Gwon Y; Kim C; Koh JY; Jung YK
Hum Mol Genet; 2012 Jun; 21(12):2725-37. PubMed ID: 22419736
[TBL] [Abstract][Full Text] [Related]
26. A novel transgenic mouse expressing double mutant tau driven by its natural promoter exhibits tauopathy characteristics.
Rosenmann H; Grigoriadis N; Eldar-Levy H; Avital A; Rozenstein L; Touloumi O; Behar L; Ben-Hur T; Avraham Y; Berry E; Segal M; Ginzburg I; Abramsky O
Exp Neurol; 2008 Jul; 212(1):71-84. PubMed ID: 18490011
[TBL] [Abstract][Full Text] [Related]
27. Tau pathology in Alzheimer disease and other tauopathies.
Iqbal K; Alonso Adel C; Chen S; Chohan MO; El-Akkad E; Gong CX; Khatoon S; Li B; Liu F; Rahman A; Tanimukai H; Grundke-Iqbal I
Biochim Biophys Acta; 2005 Jan; 1739(2-3):198-210. PubMed ID: 15615638
[TBL] [Abstract][Full Text] [Related]
28. Rifampicin is a candidate preventive medicine against amyloid-β and tau oligomers.
Umeda T; Ono K; Sakai A; Yamashita M; Mizuguchi M; Klein WL; Yamada M; Mori H; Tomiyama T
Brain; 2016 May; 139(Pt 5):1568-86. PubMed ID: 27020329
[TBL] [Abstract][Full Text] [Related]
29. Expression of P301L-hTau in mouse MEC induces hippocampus-dependent memory deficit.
Liu X; Zeng K; Li M; Wang Q; Liu R; Zhang B; Wang JZ; Shu X; Wang X
Sci Rep; 2017 Jun; 7(1):3914. PubMed ID: 28634382
[TBL] [Abstract][Full Text] [Related]
30. Activity-dependent release of phosphorylated human tau from Drosophila neurons in primary culture.
Ismael S; Sindi G; Colvin RA; Lee D
J Biol Chem; 2021 Oct; 297(4):101108. PubMed ID: 34473990
[TBL] [Abstract][Full Text] [Related]
31. Extracellular Vesicles Isolated from Familial Alzheimer's Disease Neuronal Cultures Induce Aberrant Tau Phosphorylation in the Wild-Type Mouse Brain.
Aulston B; Liu Q; Mante M; Florio J; Rissman RA; Yuan SH
J Alzheimers Dis; 2019; 72(2):575-585. PubMed ID: 31594233
[TBL] [Abstract][Full Text] [Related]
32. SH-SY5Y-derived neurons: a human neuronal model system for investigating TAU sorting and neuronal subtype-specific TAU vulnerability.
Bell M; Zempel H
Rev Neurosci; 2022 Jan; 33(1):1-15. PubMed ID: 33866701
[TBL] [Abstract][Full Text] [Related]
33. A brain-penetrant triazolopyrimidine enhances microtubule-stability, reduces axonal dysfunction and decreases tau pathology in a mouse tauopathy model.
Zhang B; Yao Y; Cornec AS; Oukoloff K; James MJ; Koivula P; Trojanowski JQ; Smith AB; Lee VM; Ballatore C; Brunden KR
Mol Neurodegener; 2018 Nov; 13(1):59. PubMed ID: 30404654
[TBL] [Abstract][Full Text] [Related]
34. Human TAU
Cosacak MI; Bhattarai P; Bocova L; Dzewas T; Mashkaryan V; Papadimitriou C; Brandt K; Hollak H; Antos CL; Kizil C
Sci Rep; 2017 Oct; 7(1):12959. PubMed ID: 29021554
[TBL] [Abstract][Full Text] [Related]
35. The toxin MPTP generates similar cognitive and locomotor deficits in hTau and tau knock-out mice.
Gratuze M; Josset N; Petry FR; Pflieger M; Eyoum Jong L; Truchetti G; Poitras I; Julien J; Bezeau F; Morin F; Samadi P; Cicchetti F; Bretzner F; Planel E
Brain Res; 2019 May; 1711():106-114. PubMed ID: 30641037
[TBL] [Abstract][Full Text] [Related]
36. Tau reduction prevents neuronal loss and reverses pathological tau deposition and seeding in mice with tauopathy.
DeVos SL; Miller RL; Schoch KM; Holmes BB; Kebodeaux CS; Wegener AJ; Chen G; Shen T; Tran H; Nichols B; Zanardi TA; Kordasiewicz HB; Swayze EE; Bennett CF; Diamond MI; Miller TM
Sci Transl Med; 2017 Jan; 9(374):. PubMed ID: 28123067
[TBL] [Abstract][Full Text] [Related]
37. Phosphorylated p38MAPK specific antibodies cross-react with sarkosyl-insoluble hyperphosphorylated tau proteins.
Sahara N; Vega IE; Ishizawa T; Lewis J; McGowan E; Hutton M; Dickson D; Yen SH
J Neurochem; 2004 Aug; 90(4):829-38. PubMed ID: 15287888
[TBL] [Abstract][Full Text] [Related]
38. Insulin deprivation induces PP2A inhibition and tau hyperphosphorylation in hTau mice, a model of Alzheimer's disease-like tau pathology.
Gratuze M; Julien J; Petry FR; Morin F; Planel E
Sci Rep; 2017 Apr; 7():46359. PubMed ID: 28402338
[TBL] [Abstract][Full Text] [Related]
39. Increased tau phosphorylation follows impeded dopamine clearance in a P301L and novel P301L/COMT-deleted (DM) tau mouse model.
Koppel J; Jimenez H; Adrien L; H Chang E; Malhotra AK; Davies P
J Neurochem; 2019 Jan; 148(1):127-135. PubMed ID: 30238463
[TBL] [Abstract][Full Text] [Related]
40. AMP-activated protein kinase modulates tau phosphorylation and tau pathology in vivo.
Domise M; Didier S; Marinangeli C; Zhao H; Chandakkar P; Buée L; Viollet B; Davies P; Marambaud P; Vingtdeux V
Sci Rep; 2016 May; 6():26758. PubMed ID: 27230293
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]